LaChapelle Robin 内部人交易:近期 SEC Form 4 交易
过去 18 个月,LaChapelle Robin(CIK 2009136)在 1 家公司共报告 8 笔 SEC Form 4 内部人交易(最近一笔 2026-11-02)。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-02 | ArriVent BioPharma, Inc. (AVBP) | Chief Operating Officer | 买入 | 16,265 | $59,374 |
| 2026-11-02 | ArriVent BioPharma, Inc. (AVBP) | Chief Operating Officer | 买入 | 410 | $935 |
| 2026-11-02 | ArriVent BioPharma, Inc. (AVBP) | Chief Operating Officer | 买入 | 4,550 | $10,381 |
| 2026-11-02 | ArriVent BioPharma, Inc. (AVBP) | Chief Operating Officer | 买入 | 1,820 | $4,152 |
| 2026-11-02 | ArriVent BioPharma, Inc. (AVBP) | Chief Operating Officer | 买入 | 17,648 | $110,055 |
| 2025-07-15 | ArriVent BioPharma, Inc. (AVBP) | Chief Operating Officer | 买入 | 2,050 | $4,674 |
| 2025-07-15 | ArriVent BioPharma, Inc. (AVBP) | Chief Operating Officer | 买入 | 2,600 | $5,928 |
| 2025-07-15 | ArriVent BioPharma, Inc. (AVBP) | Chief Operating Officer | 买入 | 6,503 | $14,827 |
来源:SEC Form 4 申报文件 · 截至 2026-11-02